Alibaba
BABA
Broadcom
AVGO
Meta Platforms
META
Alphabet-C
GOOG
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
CLSD Clearside Biomedical
- 0.930
- -0.003-0.34%
Close Jan 24 16:00 ET
- 0.940
- +0.010+1.11%
Post 20:01 ET
70.53MMarket Cap-2.07P/E (TTM)
0.943High0.900Low115.85KVolume0.915Open0.933Pre Close107.08KTurnover0.17%Turnover RatioLossP/E (Static)75.84MShares2.12052wk High-2.03P/B65.31MFloat Cap0.80152wk Low--Dividend TTM70.22MShs Float25.080Historical High--Div YieldTTM4.65%Amplitude0.560Historical Low0.924Avg Price1Lot Size
Clearside Biomedical News
Sector Update: Health Care Stocks Softer Late Afternoon
Clearside's Partner Receives NDA Approvals for Uveitic Macular Edema Treatment in Australia, Singapore
Express News | Clearside Biomedical Announces Its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and Singapore
Clearside Biomedical's Dr. Victor Chong Shares Key Insights on Drug Development in Ophthalmology at Edridge Green Lecture
Clearside Biomedical Announces Publication of Critical Insights Into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye
Clearside Biomedical Highlights Advancements in Drug Delivery
Here's Why Clearside Biomedical (CLSD) Is a Great 'Buy the Bottom' Stock Now
Clearside Biomedical Is Maintained at Buy by Chardan Capital
Clearside Biomedical Third Quarter 2024 Earnings: Beats Expectations
JonesTrading Maintains Clearside Biomedical(CLSD.US) With Buy Rating, Maintains Target Price $6
Promising Outlook for Clearside Biomedical: Buy Rating Backed by Strong Phase 2b ODYSSEY Trial Data and Robust Cash Position
Oppenheimer Maintains Clearside Biomedical(CLSD.US) With Buy Rating, Maintains Target Price $5
Needham Maintains Clearside Biomedical(CLSD.US) With Buy Rating, Maintains Target Price $6
Express News | Needham Reiterates Buy on Clearside Biomedical, Maintains $6 Price Target
Clearside Biomedical Analyst Ratings
Clearside Biomedical | 10-Q: Q3 2024 Earnings Report
Clearside Biomedical, Inc. (CLSD) Q3 2024 Earnings Conference Call Transcript Summary
Clearside Biomedical, Inc. (CLSD) Q3 2024 Earnings Conference Call Transcript
Express News | Clearside Biomedical Inc: Believes It Will Have Sufficient Resources to Fund Its Planned Operations Into Q3 of 2025
Clearside Biomedical | 8-K: Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.